A small but encouraging clinical study may hold some promise for patients coping with malignant mesothelioma that has not responded to chemotherapy treatment. The study was just reported in the October issue of the British medical journal The Lancet Oncology. One of the most exciting aspects of the study is the fact that it was done on human volunteers with malignant mesothelioma. Typically studies of this type use laboratory mice or fruit flies as study subjects making the applicability of the results to the human body uncertain. Less exciting is that the study size was relatively small … [Read more...]